Berger Franklin M

Director at AVIR; Director at ESSA Pharma Inc.; Director at FIVE PRIME THERAPEUTICS INC, and 1 more

Sold, on record
$2.6M
Dollars the filings state
Form 4 sales
5
Latest Dec 10, 2024
Form 144 notices
1
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Immune Design Corp.Unusual
    Dec 16, 2016 2016

    Sold 50,000 shares at $6.55 ($328k)

    Berger Franklin M, Director

    Sold 66.7% of holdings ($491k position)25,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale FIVE PRIME THERAPEUTICS INCUnusual
    Dec 3, 2019 +1082 days

    Sold 79,980 shares at $3.97 ($317k)

    Berger Franklin M, Director

    Sold 94.1% of holdings ($337k position)5,000 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale AVIRPlan not stated
    Nov 14, 2022 +1077 days

    Sold 41,666 shares at $5.15 ($215k)

    Berger Franklin M, Director

    Sold 5.1% of holdings ($4.2M position)778,353 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale ESSA Pharma Inc.Unusual
    Dec 21, 2022 +37 days

    Sold 272,840 shares at $2.67 ($729k)

    Berger Franklin M, Director

    Sold 28.5% of holdings ($2.6M position)684,404 shares leftFirst sale on recordFiling

  5. 5 Form 144 notice AVIRNotice
    Dec 10, 2024 +720 days

    Filed to sell 359,606 shares ($1M)

    Berger Franklin M, Lead Independent Director

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale AVIRUnusual
    Dec 10, 2024 same day

    Sold 359,606 shares at $2.85 ($1M)

    Berger Franklin M, Director

    No 10b5-1 planSold 44.3% of holdings ($2.3M position)451,897 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Berger Franklin M
Source
Dec 10, 2024Dec 12, 2024AVIRDirectorForm 4 sale359,606$1M44.3%UnusualSEC
Dec 10, 2024Dec 10, 2024AVIRLead Independent DirectorForm 144 notice359,606$1MNoticeSEC
Dec 21, 2022Jan 5, 2023ESSA Pharma Inc.DirectorForm 4 sale272,840$729k28.5%UnusualSEC
Nov 14, 2022Nov 15, 2022AVIRDirectorForm 4 sale41,666$215k5.1%Plan not statedSEC
Dec 3, 2019Dec 4, 2019FIVE PRIME THERAPEUTICS INCDirectorForm 4 sale79,980$317k94.1%UnusualSEC
Dec 16, 2016Dec 20, 2016Immune Design Corp.DirectorForm 4 sale50,000$328k66.7%UnusualSEC